Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BUB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HTN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
PDCL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CNOT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TNNI2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
G6PC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
BATF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCL3L3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRKAG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FASTK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GNAS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPP30 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HNF1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZSWIM8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IGHM - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYP2C9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
F9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RIBC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on